Author:
Xia Zu-Guang,Xu Zi-Zhen,Zhao Wei-Li,Zhao Shu-Qing,Ding Fei,Chen Yu,Chen Qiu-Sheng,Zheng Yu,Zhu Qi,Hu Jun-Pei,Shen Zhi-Xiang,Li Jun-Min
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference34 articles.
1. Jaffe ES, Harris NL, Stein H et al (2001) World Health Organization classification of tumors: pathology and genetics of tumors of hematopoetic and lymphoid tissues. IARC Press, Lyon, France
2. Li JM, Wang L, Shen Y et al (2007) Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients. Ann Hematol 86:639–645
3. Abramson JS, Shipp MA (2005) Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106:1164–1174
4. Fisher RI, Gaynor ER, Dahlberg S et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328:1002–1006
5. Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235–242
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献